CGEM fundamentals
Key facts
Market capitalization493.26 MUSD
Basic EPS (TTM)−3.14USD
Founded2016
CEONadim Ahmed
Websitecullinantherapeutics.com
About
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−48.00 M
−36.00 M
−24.00 M
−12.00 M
0.00
Revenue
Net income
Net margin %
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
CGEM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company